Skip to main content

Bank of New York Mellon Corp

Bank

Position in KROS — Keros Therapeutics, Inc.

CIK 1390777 NEW YORK, NY

Position in KROS

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$1,105,725
-$229,494 QoQ
Shares Held
103,339
-14.6% QoQ
Ownership
0.521%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 131 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 85% Shared 0% None 15%

Common Shares in KROS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. KROS ranks #188 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KROS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,105,725 103,339
2026-03-31 $1,335,219 120,944
2025-12-31 $2,475,407 121,582
2025-09-30 $1,754,151 110,882
2025-06-30 $1,459,807 109,349
2025-03-31 $996,120 97,755
2024-12-31 $1,549,404 97,878
2024-09-30 $5,540,803 95,416
2024-06-30 $5,410,328 118,388
2024-03-31 $6,595,703 99,633
2023-12-31 $3,757,476 94,504
2023-09-30 $4,603,756 144,409
2023-06-30 $4,083,812 101,638
2023-03-31 $5,661,035 132,577
2022-12-31 $4,510,373 93,927
2022-09-30 $2,803,328 74,517
2022-06-30 $1,292,337 46,773
2022-03-31 $2,526,059 46,452
2021-12-31 $2,709,012 46,300
2021-09-30 $1,699,298 42,955
2021-06-30 $1,629,149 38,360
2021-03-31 $2,629,969 42,729
2020-12-31 $3,022,850 42,853
2020-09-30 $698,309 18,105
2020-06-30 $682,305 18,190